Marwan Bukhari talks about the rationale behind investigating baricitinib and other JAK inhibitors for the treatment of COVID-19 and outlines the current efficacy data.
Негізгі бет Repurposing rheumatology drugs for COVID-19: JAK inhibitors
No video
Пікірлер